Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?
Dahlöf
C G
CG
Gothenburg Migraine Clinic, Sweden.
Mathew
N
N
D000368:Aged; D002637:Chest Pain / Q000139:chemically induced* / Q000175:diagnosis; D000075202:Contraindications; D003326:Coronary Circulation / Q000187:drug effects*; D016757:Death, Sudden, Cardiac / Q000209:etiology; D003937:Diagnosis, Differential; D004452:Echocardiography; D004562:Electrocardiography; D015155:Esophageal Spasm, Diffuse / Q000139:chemically induced* / Q000175:diagnosis; D004947:Esophagus / Q000294:innervation; D005260:Female; D006321:Heart / Q000294:innervation; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000139:chemically induced* / Q000175:diagnosis; D019547:Neck Pain / Q000139:chemically induced / Q000175:diagnosis; D017288:Pain Threshold; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin / Q000187:drug effects* / Q000502:physiology; D017366:Serotonin Receptor Agonists / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D018170:Sumatriptan / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D014661:Vasoconstriction / Q000187:drug effects
C470302:HTR1B protein, human; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D018170:Sumatriptan